Cargando…
Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer
BACKGROUND: Cisplatin and carboplatin are the primary first-line therapies for the treatment of ovarian cancer. However, resistance to these platinum-based drugs occurs in the large majority of initially responsive tumors, resulting in fully chemoresistant, fatal disease. Although the precise mechan...
Autores principales: | Li, Meng, Balch, Curt, Montgomery, John S, Jeong, Mikyoung, Chung, Jae Hoon, Yan, Pearlly, Huang, Tim HM, Kim, Sun, Nephew, Kenneth P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712480/ https://www.ncbi.nlm.nih.gov/pubmed/19505326 http://dx.doi.org/10.1186/1755-8794-2-34 |
Ejemplares similares
-
The Influence of cis-Regulatory Elements on DNA Methylation Fidelity
por: Teng, Mingxiang, et al.
Publicado: (2012) -
Integrated analysis of genome-wide DNA methylation and gene expression profiles in molecular subtypes of breast cancer
por: Rhee, Je-Keun, et al.
Publicado: (2013) -
Decitabine reactivated pathways in platinum resistant ovarian cancer
por: Fang, Fang, et al.
Publicado: (2014) -
Empirical Bayes Model Comparisons for Differential Methylation Analysis
por: Teng, Mingxiang, et al.
Publicado: (2012) -
Probe signal correction for differential methylation hybridization experiments
por: Potter, Dustin P, et al.
Publicado: (2008)